Breaks Categories: Stock Spotlights

ThursdayMar 30, 2017 1:15 pm

NetworkNewsBreaks – ProBility Media Corp. (PBYA) on Par with Skilled Trade Market; Develops Technical Training Brand For Over 60 Skilled Professions

The field for technical training is ripe, as the Bureau of Labor Statistics (BLS) forecasts continued growth for skilled trades. ProBility Media (OTCQB: PBYA) is a growing educational technology company developing the first full service training and career advancement brand for technical vocations and trades – right on par with the demand for career advancement for technical vocations and trades. “ProBility is the only company building the full spectrum of career training, advancement and compliance tools for tradesmen and technical experts in a wide variety of over 60 skilled professions. ProBility is executing a disruptive strategy of defragmenting the marketplace…

Continue Reading

ThursdayMar 30, 2017 10:33 am

NetworkNewsBreaks – MySize (NASDAQ: MYSZ) Trades Higher on Commercial Phase of KatzID Development

MySize (NASDAQ: MYSZ) shares are up 19% this morning after the company said it has completed the beta-pilot testing phase and has initiated the commercial phase of KatzID, a courier measurement application developed by MySize. KatzID will enable employees of Katz Corporation to easily and quickly measure the size of a parcel and calculate its exact shipping cost. The application also delivers barcode scanning, package pictures, location and more, which connect to Katz' ERP system to better manage their delivery processes. "Today marks a major milestone in the development of a very important product that is going to significantly improve…

Continue Reading

WednesdayMar 29, 2017 1:09 pm

NetworkNewsBreaks – Innocoll (NASDAQ: INNL) Receives FDA Meeting Minutes for XARACOLL® NDA; Shares Rally

Innocoll Holdings (NASDAQ: INNL) shares soared as much as 43% this morning – currently up 14% - after the company said it received formal Type A Meeting minutes from the United States Food and Drug Administration (FDA) relating to its New Drug Application (NDA) for XARACOLL. This clarifies the data that the company will need in order to address the questions raised in the Refusal to File (RTF) Letter the company received from the FDA in December 2016. During the Type A meeting, representatives of the FDA provided guidance which was confirmed in the formal FDA meeting minutes. The company…

Continue Reading

WednesdayMar 29, 2017 11:10 am

NetworkNewsBreaks – Players Network, Inc. (PNTV) Presenting at America First Investment Luncheon on March 31, 2017

Players Network’s (OTCQB: PNTV) CEO Mark Bradley and Director Brett H. Pojunis are set to present at the "America First Investment" financial luncheon hosted by ClubsCorp Business Network in Las Vegas on March 31, 2017, from 12:30-3:00 p.m. PDT. The diversified holding company was invited to present at the luncheon series that features select emerging companies who will present to attending investment bankers, institutional investors, and individual accredited investors. In addition to the presentation, both Bradley and Pojunis will be available for one-on-one meetings with investors. To register visit: https://goo.gl/gnkPRJ To view the full press release, visit: http://nnw.fm/Z3TrT About Players…

Continue Reading

TuesdayMar 28, 2017 10:58 am

NetworkNewsBreaks – Cempra, Inc. (NASDAQ: CEMP) Pulls Marketing Authorization Application for Solithromycin in Europe

Shares of Cempra (NASDAQ: CEMP) are down 5% mid-morning after the company said that it has withdrawn its marketing authorization application (MAA) seeking European Medicines Agency (EMA) approval of oral capsule and intravenous formulations of solithromycin for the treatment of community-acquired pneumonia in adults. The decision to withdraw was made based off of the Day 120 questions from the EMA, which caused the company to believe that additional data would be required. The company is now able to realign its strategy to provide additional data to both the EMA and U.S. Food and Drug Administration (FDA) to support potential approval.…

Continue Reading

TuesdayMar 28, 2017 10:45 am

NetworkNewsBreaks – Akers Biosciences, Inc. (NASDAQ: AKER) Receives Initial Order for Cholesterol Test from First Check; Shares Surge

Shares of Akers Biosciences (NASDAQ: AKER) climbed 71% on news of the company receiving an initial order for its rapid cholesterol self-test from First Check Diagnostics, LLC, the exclusive distributor for this product in the United States, for sale under its popular "First Check" brand. Akers’ Tri-Cholesterol "Check" test provides an estimate of a person's total cholesterol as well as his or her high density lipoprotein cholesterol levels, or 'good cholesterol'. This provides the user with an estimate of his or her low density lipoprotein levels, or 'bad cholesterol', making it an effective screening test for high cholesterol. "I am…

Continue Reading

TuesdayMar 28, 2017 10:41 am

NetworkNewsBreaks – RXi Pharmaceuticals Corp. (NASDAQ: RXII) Strengthens RXI-109 Intellectual Property with New Patent in Japan; Shares Rise

RXi Pharmaceuticals (NASDAQ: RXII) shares are up more than 38% this morning after the company said it has been granted a patent by the Japan Patent Office for the composition of matter of sd-rxRNAs targeting connective tissue growth factor for the treatment or prevention of fibrotic disorders. Fibrotic disorders covered include, but are not limited to, skin fibrosis and proliferative retinopathy. This patent includes RXI-109, the company’s lead clinical candidate, which is currently being evaluated in phase 2 clinical trials. The patent will expire in 2031. "The granting of this patent in Japan further strengthens RXi's intellectual property estate for…

Continue Reading

ThursdayMar 23, 2017 12:55 pm

NetworkNewsBreaks – ImmuDyne, Inc. (IMMD) Shares Surge on Completed Formulation of Shapiro MD Product Line

ImmuDyne (OTCQB: IMMD) shares are 21.5% higher mid-day following early news that all formulation work has been completed on the Shapiro MD product line. The first product run will transpire in the next 2-3 weeks, and a national product launch is anticipated no later than April 15, 2017. The all natural and patented hair loss product line will include shampoo, conditioner, and a once-daily leave-in foam product. "We’re very excited for the product launch and are very optimistic that the 10 years we invested in research and development to create Shapiro MD will benefit people around the world that want…

Continue Reading

ThursdayMar 23, 2017 12:53 pm

NetworkNewsBreaks – Egalet Corp. (NASDAQ: EGLT) Receives New U.S. and International Patents for Guardian™ Technology

Shares of Egalet (NASDAQ: EGLT) are up 4.5% mid-day on word the company has received new U.S. and international patents for its proprietary Guardian™ Technology, bringing the number to 18 U.S. patents and 95 international patents. The United States Patent and Trademark Office (USPTO) has issued a patent covering the company’s ARYMO™ ER extended-release tablets for oral use only. It is the second U.S. patent covering ARYMO ER and offers protection through 2033 and is listed in the Orange Book. A European patent has also been issued to Egalet and offers protection of products developed using Guardian Technology. Additionally, an…

Continue Reading

ThursdayMar 23, 2017 12:50 pm

NetworkNewsBreaks – Sphere 3D Corp.’s (NASDAQ: ANY) HVE Solution Selected by The Beck Group for VDI; Shares Higher

Shares of Sphere 3D (NASDAQ: ANY) are trading higher after the company this morning said that The Beck Group has successfully employed an HVE solution for its Virtual Desktop Infrastructure (VDI), including VDI for GPU intensive workloads. The inclusion of the HVE 3DGFX appliances for running computer aided design (CAD) applications provides a powerful server-based computing environment for The Beck Group. The CAD data processed by the server provides a faster, more effective utilization of resources and enables staff to access their workloads from any device, anywhere. “We are delighted to have the opportunity to provide them with a high…

Continue Reading